ANPC AnPac Bio-Medical Science Co., Ltd. ADRs of Class A

Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. This is an ADR of a company that does not have its stock publicly traded anywhere else in the world.

$4.90  +0.05 (1.03%)
As of 05/07/2021 09:48:23 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  China
Country of incorporation:  
IPO date:  01/30/2020
Outstanding shares:  8,338,260
Average volume:  332,884
Market cap:   $40,440,561
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    
ISIN:        
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   13.27
PS ratio:   24.10
Return on equity:   -2,477.29%
Net income %:   -673.40%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy